HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
4d
Interesting Engineering on MSNRevolutionary HIV injection could offer a full year of protection in just one doseA groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...
THI Edit page article on HIV-Self Testing (HIVST) in Mizoram entitled, "From stigma to solutions" (March 8) is interesting ...
Sarah Macadam, chief executive of Thames Valley Positive Support, expects the A&E testing will lead to an increase in demand ...
22h
New Vision on MSNHIV testing kits with tampered expiry dates recovered in NDA operationTen suspects were arrested on Saturday (March 15) in a sweeping operation conducted by the National Drug Authority (NDA) in Kampala, during which government drugs and tampered-with diagnostic kits ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results